 Jerry Rudy
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory | 23 | 2026 | 300 | 5.220 |
Why?
| | Hippocampus | 32 | 2026 | 989 | 3.310 |
Why?
| | Fear | 21 | 2011 | 373 | 2.190 |
Why?
| | Amygdala | 7 | 2009 | 203 | 1.400 |
Why?
| | Conditioning, Classical | 13 | 2011 | 120 | 1.380 |
Why?
| | Long-Term Potentiation | 6 | 2026 | 206 | 0.880 |
Why?
| | Protein Multimerization | 1 | 2026 | 205 | 0.860 |
Why?
| | Dendritic Spines | 2 | 2014 | 70 | 0.810 |
Why?
| | Actin Cytoskeleton | 2 | 2014 | 103 | 0.810 |
Why?
| | Rats | 39 | 2012 | 5613 | 0.760 |
Why?
| | Association Learning | 5 | 2007 | 70 | 0.760 |
Why?
| | Discrimination Learning | 4 | 2006 | 53 | 0.690 |
Why?
| | Mental Recall | 4 | 2007 | 225 | 0.650 |
Why?
| | Memory Disorders | 7 | 2008 | 198 | 0.640 |
Why?
| | Exploratory Behavior | 3 | 2006 | 85 | 0.620 |
Why?
| | Protein Kinase C | 3 | 2026 | 251 | 0.610 |
Why?
| | Anisomycin | 5 | 2007 | 7 | 0.590 |
Why?
| | Behavior, Animal | 12 | 2010 | 530 | 0.580 |
Why?
| | Rats, Long-Evans | 12 | 2012 | 128 | 0.580 |
Why?
| | Receptors, AMPA | 3 | 2014 | 147 | 0.570 |
Why?
| | Animals | 50 | 2026 | 38410 | 0.510 |
Why?
| | Neural Pathways | 4 | 2008 | 320 | 0.510 |
Why?
| | Protein Synthesis Inhibitors | 3 | 2007 | 48 | 0.470 |
Why?
| | Environment | 3 | 2006 | 297 | 0.450 |
Why?
| | Corpus Striatum | 3 | 2012 | 181 | 0.430 |
Why?
| | Maze Learning | 3 | 2016 | 105 | 0.370 |
Why?
| | Spatial Memory | 2 | 2026 | 27 | 0.360 |
Why?
| | Escherichia coli Infections | 6 | 2009 | 125 | 0.350 |
Why?
| | Cues | 4 | 2011 | 329 | 0.350 |
Why?
| | Microinjections | 7 | 2010 | 92 | 0.320 |
Why?
| | Freezing Reaction, Cataleptic | 5 | 2012 | 27 | 0.310 |
Why?
| | Parahippocampal Gyrus | 1 | 2009 | 11 | 0.300 |
Why?
| | Methoxyhydroxyphenylglycol | 1 | 2009 | 13 | 0.300 |
Why?
| | Mental Processes | 1 | 2009 | 37 | 0.300 |
Why?
| | Learning | 4 | 2008 | 446 | 0.290 |
Why?
| | Rats, Sprague-Dawley | 14 | 2012 | 2542 | 0.290 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2009 | 37 | 0.290 |
Why?
| | Time Factors | 12 | 2016 | 7173 | 0.280 |
Why?
| | Prefrontal Cortex | 3 | 2010 | 342 | 0.250 |
Why?
| | Muscimol | 5 | 2008 | 23 | 0.250 |
Why?
| | GABA Agonists | 5 | 2008 | 24 | 0.250 |
Why?
| | Adaptation, Psychological | 1 | 2012 | 736 | 0.240 |
Why?
| | Excitatory Amino Acid Antagonists | 4 | 2012 | 108 | 0.240 |
Why?
| | Genes, Immediate-Early | 1 | 2006 | 26 | 0.230 |
Why?
| | Amnesia | 1 | 2006 | 47 | 0.230 |
Why?
| | Brain | 3 | 2014 | 3009 | 0.230 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 233 | 0.220 |
Why?
| | Electroshock | 4 | 2009 | 146 | 0.220 |
Why?
| | Protein Biosynthesis | 1 | 2007 | 452 | 0.210 |
Why?
| | Space Perception | 1 | 2004 | 82 | 0.200 |
Why?
| | History, 21st Century | 1 | 2025 | 227 | 0.200 |
Why?
| | Stress, Physiological | 2 | 2009 | 445 | 0.200 |
Why?
| | History, 20th Century | 1 | 2025 | 333 | 0.200 |
Why?
| | Corticosterone | 2 | 2002 | 241 | 0.170 |
Why?
| | Interleukin-1beta | 3 | 2008 | 394 | 0.170 |
Why?
| | Cognition | 4 | 2006 | 1286 | 0.170 |
Why?
| | Male | 32 | 2016 | 73950 | 0.160 |
Why?
| | Extinction, Psychological | 2 | 2012 | 92 | 0.160 |
Why?
| | RNA, Messenger | 5 | 2012 | 2812 | 0.160 |
Why?
| | Analysis of Variance | 6 | 2010 | 1302 | 0.150 |
Why?
| | Conditioning, Operant | 2 | 2012 | 94 | 0.150 |
Why?
| | Models, Biological | 1 | 2007 | 1772 | 0.150 |
Why?
| | Transcription Factors | 1 | 2007 | 1747 | 0.150 |
Why?
| | Aging | 5 | 2016 | 1992 | 0.150 |
Why?
| | Gene Expression Regulation | 3 | 2010 | 2625 | 0.140 |
Why?
| | Animals, Newborn | 5 | 2007 | 914 | 0.120 |
Why?
| | Enzyme Inhibitors | 2 | 2012 | 822 | 0.110 |
Why?
| | Denervation | 2 | 2007 | 27 | 0.110 |
Why?
| | Rats, Inbred F344 | 4 | 2016 | 269 | 0.110 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2007 | 155 | 0.110 |
Why?
| | Post-Synaptic Density | 1 | 2014 | 12 | 0.110 |
Why?
| | Neuronal Plasticity | 2 | 2008 | 311 | 0.110 |
Why?
| | Interleukin-1 | 5 | 2006 | 961 | 0.110 |
Why?
| | Neuroimmunomodulation | 2 | 2012 | 67 | 0.100 |
Why?
| | Immobilization | 2 | 2004 | 54 | 0.100 |
Why?
| | Bacterial Infections | 2 | 2006 | 247 | 0.100 |
Why?
| | Models, Neurological | 3 | 2005 | 253 | 0.100 |
Why?
| | Acoustic Stimulation | 3 | 2011 | 334 | 0.100 |
Why?
| | Humans | 12 | 2026 | 147293 | 0.100 |
Why?
| | Lipopolysaccharides | 5 | 2007 | 863 | 0.090 |
Why?
| | Valine | 1 | 2012 | 83 | 0.090 |
Why?
| | Memory, Short-Term | 2 | 2006 | 271 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 269 | 0.080 |
Why?
| | 2-Amino-5-phosphonovalerate | 2 | 2007 | 12 | 0.080 |
Why?
| | Synapses | 1 | 2014 | 448 | 0.080 |
Why?
| | Immunologic Factors | 1 | 2012 | 261 | 0.080 |
Why?
| | Amnesia, Retrograde | 2 | 2006 | 6 | 0.070 |
Why?
| | Indans | 1 | 2009 | 13 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2010 | 196 | 0.070 |
Why?
| | Illness Behavior | 1 | 2009 | 9 | 0.070 |
Why?
| | Anxiety Disorders | 1 | 2012 | 376 | 0.070 |
Why?
| | Receptors, Dopamine D1 | 1 | 2008 | 34 | 0.070 |
Why?
| | Genetic Determinism | 1 | 2008 | 2 | 0.070 |
Why?
| | Body Temperature Regulation | 1 | 2009 | 106 | 0.070 |
Why?
| | Odorants | 1 | 2008 | 114 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 789 | 0.060 |
Why?
| | Brain Injuries | 1 | 2012 | 508 | 0.060 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2007 | 138 | 0.060 |
Why?
| | Foreign-Body Reaction | 1 | 2007 | 34 | 0.060 |
Why?
| | Multiprotein Complexes | 1 | 2007 | 172 | 0.060 |
Why?
| | Escape Reaction | 1 | 2006 | 55 | 0.060 |
Why?
| | Peptides | 1 | 2012 | 1003 | 0.060 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 77 | 0.060 |
Why?
| | Catheterization | 1 | 2007 | 184 | 0.060 |
Why?
| | Injections, Intraventricular | 2 | 2002 | 59 | 0.060 |
Why?
| | Pain | 1 | 2011 | 794 | 0.060 |
Why?
| | GABA-A Receptor Agonists | 1 | 2005 | 17 | 0.060 |
Why?
| | Isoenzymes | 1 | 2026 | 296 | 0.060 |
Why?
| | Logic | 1 | 2005 | 7 | 0.060 |
Why?
| | Cytoskeletal Proteins | 1 | 2006 | 158 | 0.060 |
Why?
| | Caspase Inhibitors | 1 | 2005 | 81 | 0.060 |
Why?
| | Encephalitis | 1 | 2007 | 142 | 0.050 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2004 | 42 | 0.050 |
Why?
| | N-Methylaspartate | 1 | 2004 | 43 | 0.050 |
Why?
| | Psychological Theory | 1 | 2005 | 96 | 0.050 |
Why?
| | Pattern Recognition, Visual | 1 | 2005 | 104 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2006 | 311 | 0.050 |
Why?
| | Norepinephrine | 1 | 2005 | 201 | 0.050 |
Why?
| | Problem Solving | 1 | 2005 | 156 | 0.050 |
Why?
| | Escherichia coli | 2 | 2008 | 836 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2007 | 456 | 0.050 |
Why?
| | Spatial Behavior | 1 | 2004 | 24 | 0.050 |
Why?
| | Psychomotor Performance | 1 | 2006 | 326 | 0.050 |
Why?
| | Models, Psychological | 1 | 2005 | 295 | 0.050 |
Why?
| | Neural Inhibition | 1 | 2004 | 180 | 0.050 |
Why?
| | Age Factors | 5 | 2009 | 3372 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 597 | 0.040 |
Why?
| | Smell | 1 | 2003 | 130 | 0.040 |
Why?
| | Proteins | 1 | 2007 | 1024 | 0.040 |
Why?
| | Reflex, Startle | 1 | 2002 | 75 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2030 | 0.040 |
Why?
| | Pituitary-Adrenal System | 1 | 2002 | 166 | 0.040 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2002 | 201 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2026 | 3153 | 0.040 |
Why?
| | Stress, Psychological | 1 | 2006 | 1174 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2005 | 663 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2003 | 1145 | 0.030 |
Why?
| | Amnesia, Anterograde | 2 | 2008 | 7 | 0.030 |
Why?
| | Memory, Long-Term | 1 | 2016 | 12 | 0.030 |
Why?
| | Psychological Tests | 1 | 2016 | 131 | 0.030 |
Why?
| | Disease Models, Animal | 3 | 2012 | 4604 | 0.030 |
Why?
| | Inflammation | 1 | 2006 | 2920 | 0.030 |
Why?
| | Female | 8 | 2007 | 80076 | 0.030 |
Why?
| | Dentate Gyrus | 2 | 2004 | 41 | 0.020 |
Why?
| | Freund's Adjuvant | 1 | 2011 | 18 | 0.020 |
Why?
| | Formaldehyde | 1 | 2011 | 65 | 0.020 |
Why?
| | Injections, Subcutaneous | 1 | 2011 | 170 | 0.020 |
Why?
| | Picrotoxin | 1 | 2010 | 12 | 0.020 |
Why?
| | GABA Antagonists | 1 | 2010 | 34 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2011 | 127 | 0.020 |
Why?
| | Benzophenanthridines | 1 | 2008 | 10 | 0.020 |
Why?
| | Pain Measurement | 1 | 2011 | 569 | 0.020 |
Why?
| | Mice | 1 | 2026 | 18491 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2008 | 56 | 0.020 |
Why?
| | Parietal Lobe | 1 | 2008 | 62 | 0.020 |
Why?
| | Electrodes, Implanted | 1 | 2008 | 114 | 0.020 |
Why?
| | Hypothalamus | 1 | 2008 | 164 | 0.020 |
Why?
| | Probability | 1 | 2008 | 309 | 0.020 |
Why?
| | Fever | 1 | 2009 | 320 | 0.020 |
Why?
| | Endotoxemia | 1 | 2007 | 86 | 0.020 |
Why?
| | Receptors, GABA-A | 1 | 2008 | 138 | 0.020 |
Why?
| | Spleen | 1 | 2008 | 509 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 849 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2006 | 273 | 0.010 |
Why?
| | Neuroglia | 1 | 2006 | 176 | 0.010 |
Why?
| | DNA Primers | 1 | 2006 | 505 | 0.010 |
Why?
| | Host-Pathogen Interactions | 1 | 2008 | 366 | 0.010 |
Why?
| | Caspase 1 | 1 | 2005 | 145 | 0.010 |
Why?
| | Receptors, Immunologic | 1 | 2006 | 210 | 0.010 |
Why?
| | Reaction Time | 1 | 2006 | 438 | 0.010 |
Why?
| | Drug Administration Routes | 1 | 2004 | 42 | 0.010 |
Why?
| | Body Weight | 1 | 2009 | 976 | 0.010 |
Why?
| | Avoidance Learning | 1 | 2004 | 63 | 0.010 |
Why?
| | Awareness | 1 | 2005 | 114 | 0.010 |
Why?
| | Motor Activity | 1 | 2009 | 719 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 980 | 0.010 |
Why?
| | Choice Behavior | 1 | 2005 | 181 | 0.010 |
Why?
| | Up-Regulation | 1 | 2006 | 848 | 0.010 |
Why?
| | Antigens, CD | 1 | 2006 | 562 | 0.010 |
Why?
| | Astrocytes | 1 | 2005 | 230 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 618 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 984 | 0.010 |
Why?
| | Pregnancy | 2 | 2005 | 7274 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2006 | 915 | 0.010 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2005 | 442 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1371 | 0.010 |
Why?
| | Neurons | 1 | 2006 | 1672 | 0.010 |
Why?
|
|
Rudy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|